SEZ6L2 and Alzheimer disease: SEZ6L2 showed significant upregulation in AD/ADRD cerebellum in Purkinje cells (log2FC = 1.76, q = 0.0056), with elevated expression that were more significant in ADRD cerebellum (log2FC = 3.88, q = 1.31 × 10−11).